0001288123-18-000018.txt : 20180622
0001288123-18-000018.hdr.sgml : 20180622
20180622165832
ACCESSION NUMBER: 0001288123-18-000018
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180621
FILED AS OF DATE: 20180622
DATE AS OF CHANGE: 20180622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cortis Christian
CENTRAL INDEX KEY: 0001744495
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 18915133
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0206
3
2018-06-21
0
0001098972
AGENUS INC
AGEN
0001744495
Cortis Christian
3 FORBES ROAD
LEXINGTON
MA
02421
0
1
0
0
Chief Strategy Officer
Common Stock
19849
D
Stock Option, right to buy
6.85
2016-04-13
2025-05-01
Common Stock
85000
D
Stock Option, right to buy
4.16
2017-03-31
2026-03-31
Common Stock
50000
D
Stock Option, right to buy
3.77
2018-03-31
2027-03-31
Common Stock
60000
D
Stock Option, right to buy
5.65
2019-03-02
2028-03-02
Common Stock
100000
D
Options awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan and vests in four equal annual installments beginning April 13, 2016.
Options awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan and vests in three years with one-third vested on March 31, 2017 and the balance in equal quarterly installments.
Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan and vests on-third on the one-year anniversary of the grant date, March 31, 2017, with the balance vesting in equal quarterly installments thereafter.
Options was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, and vests over three years with one-third of the award vesting on March 2, 2019 and the balance vesting in equal quarterly installments thereafter.
Christine M. Klaskin, by Power of Attorney
2018-06-22